COVID-19 accelerates the progression of atherosclerotic plaques, increasing coronary inflammation and the risk of high-risk ...
Akura Medical has enrolled the first subject in the multi-centre QUADRA-PE trial, which is assessing its flagship Katana ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback